CME
Defense: Argument for Single Agent ICI Adjuvant Treatment of Stage III Melanoma
August 18, 2023
Host: Jeffrey S. Weber, MD, PhD
Host: Jason J. Luke, MD, FACP
Host: Ryan Sullivan, MD
Host: Omid Hamid, MD
Approximately 50 - 60% of patients with melanoma have BRAF-activating tumors, meaning they are amenable to treatment with comb
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!